Product
Artemether Lumefantrine
1 clinical trial
1 indication
Indication
MalariaClinical trial
Efficacy of Artemether Lumefantrine (AL) and Dihydroartemisinin-Piperaquine (DHP) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Siaya and Bungoma Counties, KenyaStatus: Completed, Estimated PCD: 2022-12-18